Vericel (VCEL) Free Cash Flow (2010 - 2026)
Vericel (VCEL) reported Free Cash Flow of $15.1 million for Q1 2026, up 298.71% on a YoY basis from $3.8 million in Q1 2025, and up 237.26% sequentially from -$11.0 million in Q4 2025.
Vericel (VCEL) Free Cash Flow (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Free Cash Flow data on file, last reported at $15.1 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 298.71% year-over-year to $15.1 million; the trailing twelve-month figure through Mar 2026 stood at $47.5 million (up 9.0% YoY), and the FY2025 full-year result was $24.7 million, down 46.51% from the prior year.
- Free Cash Flow advanced to $15.1 million in Q1 2026, from -$11.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $60.5 million in Q4 2024 to a low of -$11.0 million in Q4 2025.
- A 5-year average of $7.1 million and a median of $4.5 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow soared 1599.18% in 2023 and slumped 255.78% in 2024, its largest moves.
- Tracing VCEL's Free Cash Flow over 5 years: stood at -$367000.0 in 2022, then soared by 1599.18% to $5.5 million in 2023, then surged by 1000.16% to $60.5 million in 2024, then plunged by 118.21% to -$11.0 million in 2025, then soared by 237.26% to $15.1 million in 2026.
- Business Quant data shows VCEL's Free Cash Flow at $15.1 million in Q1 2026, -$11.0 million in Q4 2025, and $43.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 15.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.13 Mn |
| Mar 31, 2026 | 15.13 Mn |
| Dec 31, 2025 | -11.02 Mn |
| Dec 31, 2025 | -11.02 Mn |
| Sep 30, 2025 | 43.30 Mn |
| Sep 30, 2025 | 43.30 Mn |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | -7.61 Mn |
| Mar 31, 2025 | -7.61 Mn |
| Dec 31, 2024 | 60.53 Mn |
| Dec 31, 2024 | 60.53 Mn |
| Sep 30, 2024 | -9.23 Mn |
| Sep 30, 2024 | -9.23 Mn |
| Jun 30, 2024 | -128,000.00 |
| Jun 30, 2024 | -128,000.00 |
| Mar 31, 2024 | -4.91 Mn |
| Mar 31, 2024 | -4.91 Mn |
| Dec 31, 2023 | 5.50 Mn |
| Dec 31, 2023 | 5.50 Mn |